Press Release HCW Biologics Inc. Announces Pricing of $1.6 Million Private Placement Offering 5 hours ago
Press Release HCW Biologics Reaches Milestones for Its Proprietary Tetravalent Second-Generation T-Cell Engager Program On Track To Initiate Clinical Trials in First Half 2027 Jul 23